earnings

Hillsdale Investment Management Inc. lifted its holdings in shares of Tesla, Inc. (NASDAQ:TSLA – Free Report) by 23.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 17,961 shares of the e

Lumentum Holdings' stock rises to $855 following strong Q3 results driven by AI demand. Analysts maintain a Moderate Buy rating, highlighting growth potential and valuation risks in the competitive photonics market.

Karnataka's Horticulture Department cites improved yield and long-term profitability.

On this Memorial Day, American servicemembers remain deployed across the world. Many are in harm’s way. This simple fact makes the day less abstract, more real. Memorial Day is not only about wars filed away in history, but also about lives lost in service to the nation and the obligations those los

Shares of Cal-Maine Foods, Inc. (NASDAQ:CALM – Get Free Report) have received an average recommendation of “Hold” from the five brokerages that are presently covering the company, Marketbeat Ratings reports. Four research analysts have rated the stock with a hold recommendation and one has assigned

Trican Well Service Ltd. (TSE:TCW – Get Free Report) has been given an average recommendation of “Hold” by the six research firms that are currently covering the stock, Marketbeat Ratings reports. Four research analysts have rated the stock with a hold recommendation and two have issued a buy recomm

Eurizon Capital SGR S.p.A. acquired a new stake in MetLife, Inc. (NYSE:MET – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 1,013,033 shares of the financial services provider’s stock,

AdvisorShares Investments LLC acquired a new stake in argenex SE (NASDAQ:ARGX – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 1,100 shares of the company’s stock, valued at

AdvisorShares Investments LLC boosted its position in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 82.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 28,394 shares of the specialty pharmaceut

The market hasn’t fully priced the next logical step for the AI buildout: Big Tech acquiring regulated utilities outright.